These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7485409)

  • 1. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.
    Brion JP; Couck AM
    Am J Pathol; 1995 Nov; 147(5):1465-76. PubMed ID: 7485409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease.
    Takahashi M; Iseki E; Kosaka K
    Brain Res; 2000 Apr; 862(1-2):253-6. PubMed ID: 10799694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.
    Yamaguchi H; Ishiguro K; Uchida T; Takashima A; Lemere CA; Imahori K
    Acta Neuropathol; 1996 Sep; 92(3):232-41. PubMed ID: 8870824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y; Ito H; Ihara M; Takahashi R
    Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.
    Nakamura S; Kawamoto Y; Nakano S; Akiguchi I; Kimura J
    Acta Neuropathol; 1997 Aug; 94(2):153-7. PubMed ID: 9255390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
    Shanavas A; Papasozomenos SC
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.
    Lennox G; Lowe J; Morrell K; Landon M; Mayer RJ
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):67-71. PubMed ID: 2540286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.
    Dickson DW; Schmidt ML; Lee VM; Zhao ML; Yen SH; Trojanowski JQ
    Acta Neuropathol; 1994; 87(3):269-76. PubMed ID: 7912027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K; Mandelkow EM; Biernat J; Piwnica-Worms H; Mandelkow E
    FEBS Lett; 1993 Dec; 336(3):417-24. PubMed ID: 8282104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
    Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ
    Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau.
    Pollanen MS; Bergeron C; Weyer L
    J Neurochem; 1992 May; 58(5):1953-6. PubMed ID: 1373181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.
    Pollanen MS; Bergeron C; Weyer L
    Acta Neuropathol; 1994; 88(1):1-6. PubMed ID: 7524261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I; Jicha G; Rosado M; Dickson DW
    J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
    Love S; Saitoh T; Quijada S; Cole GM; Terry RD
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis.
    Nakamura S; Kawamoto Y; Nakano S; Ikemoto A; Akiguchi I; Kimura J
    Neurology; 1997 Jan; 48(1):267-70. PubMed ID: 9008532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.